市場調査レポート
商品コード
1123767

管腔内縫合デバイスの世界市場:用途別(肥満、胃腸、胃食道逆流症)、エンドユーザー別(病院、診療所、外来手術センター)、技術分析、規制状況、動向 - 2027年までの予測

Endoluminal Suturing Devices Market by Application (Bariatric, Gastrointestinal, Gastroesophageal Reflux Disease), End User (Hospitals, Clinics, Ambulatory Surgical Centers), Technology Analysis, Regulatory Landscape, Trends - Global Forecast to 2027

出版日: | 発行: MarketsandMarkets | ページ情報: 英文 143 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
管腔内縫合デバイスの世界市場:用途別(肥満、胃腸、胃食道逆流症)、エンドユーザー別(病院、診療所、外来手術センター)、技術分析、規制状況、動向 - 2027年までの予測
出版日: 2022年08月19日
発行: MarketsandMarkets
ページ情報: 英文 143 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の管腔内縫合デバイスの市場規模は、2022年の7800万米ドルから2027年には1億3900万米ドルに成長する見通しで、CAGR12.0%で推移すると予測されます。

同市場の成長は、肥満手術の需要の高まり、手術件数の増加、消化器系疾患の有病率の上昇に大きく起因していると考えられます。

"消化器外科分野は、予測期間中に最も高いCAGRを記録すると予想される"

用途に基づき、世界の管腔内縫合デバイス市場は、肥満手術、胃腸手術、胃食道逆流症手術、その他の手術に区分されます。消化器外科分野は、予測期間中に最も高い成長を記録すると予想されます。これは主に、世界的に消化器がんの患者数が増加していることに起因しています。

"管腔内縫合デバイスのエンドユーザー市場では、予測期間中に外来医療センターセグメントが最も高い成長を遂げる"

管腔内縫合デバイス市場は、エンドユーザーに基づいて、病院、外来手術センター、診療所、その他のエンドユーザーに区分されます。外来手術センター部門は、予測期間中に最も高い成長を記録すると予想されます。これは、費用対効果の高い治療が提供されるため、外来診療の場で治療を受ける採用が増加していることに起因するものです。

"アジア太平洋は、予測期間中に最も高い成長を示す"

アジア太平洋は、2022-2027年の予測期間中に最も高いCAGRで成長すると予想されます。インド、中国、日本などの高成長市場の存在、中国やインドにおける医療産業の急速な発展、病院数の増加、一人当たり所得の上昇、医療インフラの増加、GI癌の負担増、健康に対する意識の高まりなどが、アジア太平洋における管腔内縫合デバイス市場の成長を促進する主要因として期待されています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 規制機関、政府機関、およびその他の組織
  • 規制分析
  • ポーターのファイブフォース分析
  • バリューチェーン分析
  • 業界の動向
  • 技術分析
  • エコシステム分析
  • 特許分析

第6章 用途別:管腔内縫合デバイス市場

  • イントロダクション
  • 肥満手術
  • 消化器外科
  • 胃食道逆流症の手術
  • その他の手術

第7章 エンドユーザー別:管腔内縫合デバイス市場

  • イントロダクション
  • 病院
  • クリニック
  • 外来手術センター
  • その他のエンドユーザー

第8章 地域別:管腔内縫合デバイス市場

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 概要
  • 主要企業の戦略/有力企業
  • 主要市場参入企業の収益シェア分析
  • 市場シェア分析
  • 競合ベンチマーキング
  • 企業のフットプリント
  • 企業評価クアドラント
  • 競合シナリオ

第10章 企業プロファイル

  • 主要企業
    • APOLLO ENDOSURGERY, INC.
    • JOHNSON & JOHNSON(ETHICON, INC.)
    • MEDTRONIC PLC
    • COOK GROUP INCORPORATED
    • USGI MEDICAL
    • OVESCO ENDOSCOPY AG
    • ENDO TOOLS THERAPEUTICS S.A.
    • ERGOSUTURE
    • SUTRUE LTD.

第11章 付録

目次
Product Code: MD 8153

The global endoluminal suturing devices market is projected to reach USD 139 million by 2027 from USD 78 million in 2022, at a CAGR of 12.0%. The growth of this market can largely be attributed to the rising demand for bariatric surgeries, increasing number of surgeries, and rising prevalence of gastrointestinal diseases.

"The gastrointestinal surgery segment is expected to register the highest CAGR during the forecast period"

Based on application, the global endoluminal suturing devices market is segmented into bariatric surgery, gastrointestinal surgery, gastroesophageal reflux disease surgery, and other surgeries. The gastrointestinal surgery segment is expected to register the highest growth during the forecast period. This is mainly due to the growing number of gastrointestinal cancer cases worldwide.

"The ambulatory care centers segment to witness the highest growth in the endoluminal suturing devices end user market during the forecast period"

Based on end users, the endoluminal suturing devices market is segmented into hospitals, ambulatory surgical centers, clinics, and other end users. The ambulatory care centers segment is expected to register the highest growth during the forecast period. This can be attributed to the increased adoption of getting treated in ambulatory care settings due to the cost-effective treatment offered.

"The APAC to witness the highest growth during the forecast period."

Asia Pacific is expected to grow at the highest CAGR during the forecast period of 2022-2027. The presence of high-growth markets such as India, China, and Japan, rapidly developing healthcare industry in China and India, increasing number of hospitals, rising per capita income, increasing healthcare infrastructure, rising burden of GI cancer, and the rising awareness about health are some of the major factors that are expected to drive the growth of the endoluminal suturing devices market in the Asia Pacific region.

Break of primary participants was as mentioned below:

  • By Company Type - Tier 1-35%, Tier 2-45%, and Tier 3-20%
  • By Designation - C-level-35%, Director-level-25%, Others-40%
  • By Region - North America-40%, Europe-30%, Asia Pacific-20%, Latin America- 5%, Middle East and Africa-5%

Key players in the Endoluminal suturing devices market

The prominent players in the endoluminal suturing devices market are Apollo Endosurgery, Inc. (US), Johnson & Johnson (US), Medtronic Plc (Ireland), Cook Group Incorporated (US), USGI Medical (US), Ovesco Endoscopy AG (Germany), Endo Tools Therapeutics S.A. (Belgium), ErgoSuture (US), and Sutrue Ltd. (UK).

Research Coverage:

The report analyzes the endoluminal suturing devices market and aims at estimating the market size and future growth potential of this market based on various segments such as, application, and end user. The report also includes a product portfolio matrix of various endoluminal suturing devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the endoluminal suturing devices market. The report analyzes this market by application and by end user.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoluminal suturing devices market.
  • Market Development: Comprehensive information on the lucrative emerging markets by application and by end user.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoluminal suturing devices market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoluminal suturing devices market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
    • 1.2.2 MARKETS COVERED
    • FIGURE 1 ENDOLUMINAL SUTURING DEVICES MARKET SEGMENTATION
    • 1.2.3 YEARS CONSIDERED
  • 1.3 CURRENCY CONSIDERED
    • TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD
  • 1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH APPROACH
  • 2.2 RESEARCH DESIGN
    • FIGURE 2 ENDOLUMINAL SUTURING DEVICES MARKET: RESEARCH DESIGN
    • 2.2.1 SECONDARY RESEARCH
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.2.2.1 Key data from primary sources
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
    • FIGURE 7 TOP-DOWN APPROACH
    • FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • FIGURE 9 CAGR PROJECTIONS
  • 2.4 DATA TRIANGULATION APPROACH
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.5 MARKET SHARE ESTIMATION
  • 2.6 ASSUMPTIONS
  • 2.7 LIMITATIONS
    • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
    • 2.7.2 SCOPE-RELATED LIMITATIONS
  • 2.8 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ENDOLUMINAL SUTURING DEVICES MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 12 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 13 GEOGRAPHIC SNAPSHOT OF ENDOLUMINAL SUTURING DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 ENDOLUMINAL SUTURING DEVICES MARKET OVERVIEW
    • FIGURE 14 RISING NUMBER OF SURGICAL PROCEDURES PERFORMED TO DRIVE GROWTH
  • 4.2 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION AND COUNTRY (2021)
    • FIGURE 15 GASTROINTESTINAL SURGERIES ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
  • 4.3 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.4 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION (2020-2027)
    • FIGURE 17 NORTH AMERICA TO DOMINATE ENDOLUMINAL SUTURING DEVICES MARKET IN 2027

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 ENDOLUMINAL SUTURING DEVICES MARKET: KEY DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing number of surgical procedures worldwide
    • TABLE 3 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2020
      • 5.2.1.2 Rising prevalence of gastrointestinal cancers, inflammatory bowel disease, and other digestive diseases
    • TABLE 4 GLOBAL INCIDENCE OF COLORECTAL CANCER, 2020
    • TABLE 5 GLOBAL GASTROINTESTINAL CANCER INCIDENCE, 2020
      • 5.2.1.3 Favorable reimbursement scenario
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Presence of alternative wound care management products
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 High-growth opportunities in emerging markets
    • TABLE 6 AVERAGE SURGICAL PROCEDURE COSTS (2021)
      • 5.2.3.2 Increasing adoption of outpatient surgeries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of skilled personnel
  • 5.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 NORTH AMERICA
      • 5.4.1.1 US
    • TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 9 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
      • 5.4.1.2 Canada
    • TABLE 10 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • 5.4.2 EUROPE
    • 5.4.3 ASIA PACIFIC
      • 5.4.3.1 Japan
    • TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.4.3.2 China
    • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.4.3.3 India
  • 5.5 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 13 PORTER'S FIVE FORCES ANALYSIS
    • 5.5.1 THREAT FROM NEW ENTRANTS
    • 5.5.2 THREAT FROM SUBSTITUTES
    • 5.5.3 BARGAINING POWER OF SUPPLIERS
    • 5.5.4 BARGAINING POWER OF BUYERS
    • 5.5.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 19 VALUE CHAIN ANALYSIS: MAXIMUM VALUE IS ADDED DURING MANUFACTURING PHASE
  • 5.7 INDUSTRY TRENDS
    • 5.7.1 MINIMALLY INVASIVE SURGERY
  • 5.8 TECHNOLOGY ANALYSIS
    • 5.8.1 ROBOTIC SUTURING SYSTEMS
  • 5.9 ECOSYSTEM ANALYSIS
    • FIGURE 20 SURGICAL SUTURES MARKET: ECOSYSTEM MAP (2021)
  • 5.10 PATENT ANALYSIS
    • 5.10.1 PATENT PUBLICATION TRENDS FOR ENDOLUMINAL SUTURING DEVICES
    • FIGURE 21 PATENT PUBLICATION TRENDS (JANUARY 2011-JULY 2022)
    • 5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
    • FIGURE 22 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR ENDOLUMINAL SUTURING DEVICES (JANUARY 2011-JULY 2022)
    • FIGURE 23 TOP APPLICANT JURISDICTIONS FOR ENDOLUMINAL SUTURING DEVICE PATENTS (JANUARY 2011-JULY 2022)
    • TABLE 14 LIST OF PATENTS IN ENDOLUMINAL SUTURING DEVICES MARKET, 2020-2022

6 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION

  • 6.1 INTRODUCTION
    • TABLE 15 ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
  • 6.2 BARIATRIC SURGERY
    • 6.2.1 GROWING PREVALENCE OF OBESITY TO DRIVE MARKET GROWTH
    • TABLE 16 NUMBER OF BARIATRIC SURGERIES PERFORMED GLOBALLY (2018)
    • TABLE 17 US: NUMBER OF BARIATRIC SURGERIES, 2011-2020
    • TABLE 18 ENDOLUMINAL SURGICAL DEVICES MARKET FOR BARIATRIC SURGERY, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 6.3 GASTROINTESTINAL SURGERY
    • 6.3.1 GROWING BURDEN OF COLON CANCER TO INCREASE DEMAND FOR GASTROINTESTINAL SURGERY
    • TABLE 19 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021
    • TABLE 20 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROINTESTINAL SURGERY, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 6.4 GASTROESOPHAGEAL REFLUX DISEASE SURGERY
    • 6.4.1 IMPROVING DIETS AND LIFESTYLE CHANGES TO RESTRAIN MARKET GROWTH
    • TABLE 21 ENDOLUMINAL SURGICAL DEVICES MARKET FOR GASTROESOPHAGEAL REFLUX DISEASE SURGERY, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 6.5 OTHER SURGERIES
    • TABLE 22 ENDOLUMINAL SURGICAL DEVICES MARKET FOR OTHER SURGERIES, BY COUNTRY, 2020-2027 (USD THOUSAND)

7 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER

  • 7.1 INTRODUCTION
    • TABLE 23 ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 7.2 HOSPITALS
    • 7.2.1 GROWING NUMBER OF HOSPITALS WORLDWIDE TO PROPEL MARKET GROWTH
    • TABLE 24 NUMBER OF HOSPITALS, BY COUNTRY, 2010-2021
    • TABLE 25 ENDOLUMINAL SUTURING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 7.3 CLINICS
    • 7.3.1 QUICKER CONSULTATION SERVICES AND MINIMAL PATIENT STAYS- KEY ADVANTAGES DRIVING MARKET GROWTH
    • TABLE 26 ENDOLUMINAL SUTURING DEVICES MARKET FOR CLINICS, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 7.4 AMBULATORY SURGERY CENTERS
    • 7.4.1 COST-EFFECTIVE TREATMENTS IN AMBULATORY CENTERS TO DRIVE DEMAND FOR THESE FACILITIES
    • TABLE 27 ENDOLUMINAL SUTURING DEVICES MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2020-2027 (USD THOUSAND)
  • 7.5 OTHER END USERS
    • TABLE 28 ENDOLUMINAL SUTURING DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD THOUSAND)

8 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION

  • 8.1 INTRODUCTION
    • FIGURE 24 ENDOLUMINAL SUTURING DEVICES MARKET: GEOGRAPHIC SNAPSHOT (2021)
    • TABLE 29 ENDOLUMINAL SUTURING DEVICES MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 8.2 NORTH AMERICA
    • TABLE 30 NORTH AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • FIGURE 25 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT
    • TABLE 31 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD THOUSAND)
    • TABLE 32 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 33 NORTH AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.2.1 US
      • 8.2.1.1 US to dominate North American endoluminal suturing devices market during forecast period
    • TABLE 34 US: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 35 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 36 US: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.2.2 CANADA
      • 8.2.2.1 Increasing volume of surgeries to fuel demand for endoluminal suturing devices in Canada
    • TABLE 37 CANADA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 38 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 39 CANADA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
  • 8.3 EUROPE
    • TABLE 40 EUROPE: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 41 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD THOUSAND)
    • TABLE 42 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 43 EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.1 GERMANY
      • 8.3.1.1 High penetration of health insurance makes Germany largest market for endoluminal suturing devices in Europe
    • TABLE 44 GERMANY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 45 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 46 GERMANY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.2 FRANCE
      • 8.3.2.1 Well-established healthcare system and growing procedural volume boost market growth
    • TABLE 47 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 48 FRANCE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.3 UK
      • 8.3.3.1 Growing volume of hernia repair and bowel cancer surgeries will stimulate market growth
    • TABLE 49 UK: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 50 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 51 UK: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.4 ITALY
      • 8.3.4.1 Initiatives to build awareness about digestive health to increase adoption of endoluminal suturing devices
    • TABLE 52 ITALY: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 53 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 54 ITALY: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.5 SPAIN
      • 8.3.5.1 Growing healthcare budget to drive growth in Spain
    • TABLE 55 SPAIN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 56 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 57 SPAIN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.3.6 REST OF EUROPE
    • TABLE 58 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 59 REST OF EUROPE: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
  • 8.4 ASIA PACIFIC
    • TABLE 60 ASIA PACIFIC: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • FIGURE 26 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET SNAPSHOT
    • TABLE 61 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY COUNTRY, 2020-2027 (USD THOUSAND)
    • TABLE 62 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 63 ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.4.1 JAPAN
      • 8.4.1.1 Strong healthcare system in Japan supports growth of endoluminal suturing devices market
    • TABLE 64 JAPAN: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 65 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 66 JAPAN: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.4.2 CHINA
      • 8.4.2.1 Growing number of hospitals and increased prevalence of obesity to propel growth in China
    • TABLE 67 CHINA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 68 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 69 CHINA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.4.3 INDIA
      • 8.4.3.1 Increasing prevalence of gastrointestinal disorders and favorable government support to drive market in India
    • TABLE 70 INDIA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 71 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 72 INDIA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
    • 8.4.4 REST OF ASIA PACIFIC
    • TABLE 73 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 74 REST OF ASIA PACIFIC: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
  • 8.5 LATIN AMERICA
    • 8.5.1 GROWING MEDICAL TOURISM IN LATIN AMERICAN COUNTRIES TO PROPEL MARKET
    • TABLE 75 LATIN AMERICA: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 76 BRAZIL: GASTROINTESTINAL CANCER INCIDENCE, ESTIMATED DEATHS, AND FIVE-YEAR PREVALENCE (2020)
    • TABLE 77 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 78 LATIN AMERICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)
  • 8.6 MIDDLE EAST & AFRICA
    • 8.6.1 MIDDLE EAST & AFRICA-SMALLEST REGIONAL MARKET FOR ENDOLUMINAL SUTURING DEVICES
    • TABLE 79 MIDDLE EAST & AFRICA: GASTROINTESTINAL CANCER INCIDENCE (2020)
    • TABLE 80 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY APPLICATION, 2020-2027 (USD THOUSAND)
    • TABLE 81 MIDDLE EAST & AFRICA: ENDOLUMINAL SUTURING DEVICES MARKET, BY END USER, 2020-2027 (USD THOUSAND)

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 9.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS IN ENDOLUMINAL SUTURING DEVICES MARKET
  • 9.4 MARKET SHARE ANALYSIS
    • FIGURE 28 ENDOLUMINAL SUTURING DEVICES MARKET SHARE, BY KEY PLAYER, 2021
    • TABLE 82 ENDOLUMINAL SUTURING DEVICES MARKET: DEGREE OF COMPETITION
  • 9.5 COMPETITIVE BENCHMARKING
    • TABLE 83 ENDOLUMINAL SUTURING DEVICES MARKET: COMPETITIVE BENCHMARKING
  • 9.6 COMPANY FOOTPRINT
    • TABLE 84 FOOTPRINT OF COMPANIES IN ENDOLUMINAL SUTURING DEVICES MARKET
    • 9.6.1 APPLICATION FOOTPRINT
    • TABLE 85 APPLICATION FOOTPRINT OF COMPANIES
    • 9.6.2 END-USER FOOTPRINT
    • TABLE 86 END-USER FOOTPRINT OF COMPANIES
    • 9.6.3 REGIONAL FOOTPRINT
    • TABLE 87 REGIONAL FOOTPRINT OF COMPANIES
  • 9.7 COMPANY EVALUATION QUADRANT
    • 9.7.1 STARS
    • 9.7.2 EMERGING LEADERS
    • 9.7.3 PERVASIVE PLAYERS
    • 9.7.4 PARTICIPANTS
    • FIGURE 29 ENDOLUMINAL SUTURING DEVICES MARKET: COMPANY EVALUATION QUADRANT (2021)
  • 9.8 COMPETITIVE SCENARIO
    • 9.8.1 PRODUCT LAUNCHES
    • TABLE 88 PRODUCT LAUNCHES (JANUARY 2019-JULY 2022)
    • 9.8.2 OTHER DEVELOPMENTS
    • TABLE 89 OTHER DEVELOPMENTS (JANUARY 2019-JULY 2022)

10 COMPANY PROFILES

  • 10.1 KEY PLAYERS
  • (Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments)**
    • 10.1.1 APOLLO ENDOSURGERY, INC.
    • TABLE 90 APOLLO ENDOSURGERY, INC.: BUSINESS OVERVIEW
    • FIGURE 30 APOLLO ENDOSURGERY, INC.: COMPANY SNAPSHOT (2021)
    • 10.1.2 JOHNSON & JOHNSON (ETHICON, INC.)
    • TABLE 91 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 31 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021)
    • 10.1.3 MEDTRONIC PLC
    • TABLE 92 MEDTRONIC, INC.: BUSINESS OVERVIEW
    • FIGURE 32 MEDTRONIC PLC: COMPANY SNAPSHOT (2022)
    • 10.1.4 COOK GROUP INCORPORATED
    • TABLE 93 COOK GROUP INCORPORATED: BUSINESS OVERVIEW
    • 10.1.5 USGI MEDICAL
    • TABLE 94 USGI MEDICAL: BUSINESS OVERVIEW
    • 10.1.6 OVESCO ENDOSCOPY AG
    • TABLE 95 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
    • 10.1.7 ENDO TOOLS THERAPEUTICS S.A.
    • TABLE 96 ENDO TOOLS THERAPEUTICS S.A.: BUSINESS OVERVIEW
    • 10.1.8 ERGOSUTURE
    • TABLE 97 ERGOSUTURE: BUSINESS OVERVIEW
    • 10.1.9 SUTRUE LTD.
    • TABLE 98 SUTRUE LTD.: BUSINESS OVERVIEW
  • *Business Overview, Products/Services/Solutions Offered, MnM View, Key Strengths and Right to Win, Strategic Choices Made, Weaknesses and Competitive Threats, Recent Developments might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 INSIGHTS FROM INDUSTRY EXPERTS
  • 11.2 DISCUSSION GUIDE
  • 11.3 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.4 CUSTOMIZATION OPTIONS
  • 11.5 RELATED REPORTS
  • 11.6 AUTHOR DETAILS